Cargando…
Robust positive control of tumour growth using angiogenic inhibition
In practice, many physical systems, including physiological ones, can be considered whose input can take only positive quantities. However, most of the conventional control methods do not support the positivity of the main input data to the system. Furthermore, the parameters of these systems, simil...
Autores principales: | Homayounzade, Mohamadreza, Homayounzadeh, Maryam, Khooban, Mohammad Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580019/ https://www.ncbi.nlm.nih.gov/pubmed/37787083 http://dx.doi.org/10.1049/syb2.12076 |
Ejemplares similares
-
Variable structure robust controller design for blood glucose regulation for type 1 diabetic patients: A backstepping approach
por: Homayounzade, Mohamadreza
Publicado: (2021) -
Positive input observer‐based controller design for blood glucose regulation for type 1 diabetic patients: A backstepping approach
por: Homayounzade, Mohamadreza
Publicado: (2022) -
A peptide derived from TIMP-3 inhibits multiple angiogenic growth factor receptors and tumour growth and inflammatory arthritis in mice
por: Chen, Yung-Yi, et al.
Publicado: (2013) -
The endogenous anti-angiogenic VEGF isoform, VEGF(165)b inhibits human tumour growth in mice
por: Rennel, E S, et al.
Publicado: (2008) -
Multi-scale mathematical modelling of tumour growth and microenvironments in anti-angiogenic therapy
por: Cai, Yan, et al.
Publicado: (2016)